Katherine Hill Ritchie

We are developing a novel device to prevent infection in peritoneal dialysis, a form of at-home treatment for end-stage renal disease. By minimizing the risk of infection, we enable more patients with kidney failure to receive quality care in the comforts of their own homes.

Citrine Angels is an angel investment organization composed of more than 80 women angel investors committed to empowering female founders and funders through investments, education and mentorship. Our focus is to provide the necessary resources, networks, and expertise to cultivate female angel investors into helping female-founded businesses grow and succeed. In an industry where capital disproportionately goes to men, Citrine Angels is the only angel investing organization in the mid-Atlantic region pledged solely to supporting female founders and funders. Since our founding in late 2019, our members - many of them first time angel investors - have invested more than $1.75M in female founded companies.

How Women Invest is a venture firm, and sister entity to How Women Lead, a professional network of over 24,000 women. We see that female founders are a force to be reckoned with and are part of an untapped venture capital landscape. We invest in U.S. based, female-led and female-majority owned companies in most industry sectors. With 40% of companies founded by women, generating 26% greater returns, and yet only 2% of venture backing, How Women Invest focuses at the intersection of this opportunity to create ecosystem change. To learn more about the firm: www.howwomeninvest.com and info@howwomeninvest.com.

The current management of chronic wound healing is not effective and often requires surgical approaches. Rapid Nexus Nanotech Wound Solutions. has a groundbreaking approach to treating complex non-healing chronic wounds including diabetic ulcers. Our wound management system does not require debridement. It limits infection, stimulates wound re-epithelialization, cell proliferation, extracellular matrix production and improves vascularization. The Rapid Nexus wound management system already has eliminated the need for amputations in our own patient studies. Patients or their caregivers can be trained to apply topical treatment along with our small device to stimulate uptake of the topical gel composition by the wound bed.

Portfolia is the most powerful community of women and men investing in the companies we want in the world. Our collective investments are changing health, active aging & longevity, sustainability, education, and the overall venture capital landscape while also backing diversity. Our currently open funds are Femtech III, focused on enhancing the wellness of all women, and advancing innovation in womens health; and Active Aging & Longevity II, focused on significant opportunities and challenges in aging well, as well as those focused on new strides and technologies in the field of longevity. We drive change while creating wealth. If youd like to join us, email investorrelations@portfolia.com, and our Investor Relations Team will contact you.

Operating Partner seeking to acquire a mid-size Clinical Reasearch Organization in the United Kingdom. Full deck and Data Room access upon request

Venture Forward, NVCA’s 501(c)(3) nonprofit arm, is on a mission to democratize access to the venture capital (VC) industry, empower individuals from all backgrounds and geographies to thrive as investors, and equip future VC leaders with the tools for long-term success. We support emerging fund managers and investors by providing education, mentorship, and resources to advance their careers. We are committed to driving healthy and sustainable generational change within established VC firms, ensuring strong industry stewardship for the future. Through these efforts, we envision a VC industry that reaches all communities across the country, unlocking greater innovation, economic impact, and financial returns. Learn more at ventureforward.org.

Funding and facilitating a clean energy future through the adoption of clean energy and climate mitigation products, services, and technologies in Maryland. 🦀

Materna Medical is a novel OBGYN platform company defining a $6B market with core technologies addressing unmet needs in womens pelvic health. With headquarters in Mountain View, California, Materna pulls from the top minds in MedTech to truly transform the standard of care in OBGYN. With a diverse team of engineers, scientists, researchers, and commercial leaders, Materna Medical’s mission is to empower women to protect their pelvic health.

We are developing a novel device to prevent infection in peritoneal dialysis, a form of at-home treatment for end-stage renal disease. By minimizing the risk of infection, we enable more patients with kidney failure to receive quality care in the comforts of their own homes.